BRIEF-Teva announces FDA approval of AUSTEDO tablets for treatment of chorea associated with huntington’s disease
April 3 Teva Pharmaceutical Industries Ltd -
* Teva announces FDA approval of AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated with huntington’s disease
* AUSTEDO is expected to be available in U.S. within next 3 weeks. Source text for Eikon: Further company coverage: